Episode Summary
Several weeks ago we reported on Capital Rx, a new PBM with a “clearinghouse model” designed to eliminate spread pricing and price variability — and promote greater transparency. This week, John sits down with A.J. Loiacono, a veteran entrepreneur and CEO of Capital Rx. Listen in and learn about what’s wrong with pharmaceutical pricing and how A.J. intends to fix it.
Episode Notes
Several weeks ago we reported on Capital Rx, a new PBM with a “clearinghouse model” designed to eliminate spread pricing and price variability — and promote greater transparency. This week, John sits down with A.J. Loiacono, a veteran entrepreneur and CEO of Capital Rx. Listen in and learn about what’s wrong with pharmaceutical pricing and how A.J. intends to fix it.
Speaker Bios
A.J. Loiacono, CEO, Capital Rx
A.J. is a successful entrepreneur, with 20 years of experience in pharmacy benefits and software development. As the CEO of Capital Rx, his mission is to change the way pharmacy benefits are priced and administrated in the US. Prior to Capital Rx, A.J. was a co-founder of Truveris, where he served for eight years as CEO, Chief Innovation Officer, and Board Member, leading the company to record growth (Deloitte FAST 500 and Crain’s Fast50). Prior to Truveris, A.J. co-founded SMS Partners, a joint venture with Realogy (RLGY), and in 2010 exited the partnership with a buyout. In his first venture, A.J. started Victrix, a pharmaceutical supply chain software consultancy, and successfully sold the company to Chrysalis Solutions in 2007.
John Marchica, CEO, Darwin Research Group
John Marchica is a veteran health care strategist and CEO of Darwin Research Group, a health care market intelligence firm specializing in health care delivery systems. He’s a two-time health care entrepreneur, and his first company, FaxWatch, was listed twice on the Inc. 500 list of fastest growing American companies. John is the author of The Accountable Organization and has advised senior management on strategy and organizational change for more than a decade. John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is a faculty associate in the W.P. Carey School of Business and the College of Health Solutions at Arizona State University, and is an active member of the American College of Healthcare Executives.
About Darwin Research Group
Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.
CONNECT WITH US:
🌐 Follow Health Care Rounds on LinkedIn
🌐 Follow Darwin Research Group on LinkedIn
📺 Watch Health Care Rounds on YouTube
⚙️ Health Care Rounds is produced by Grippi Media
Recommended Next
Darwin's Our Take: Feature: A rare FDA refusal, CDC grant cuts, and proposed ACA exchange changes
Darwin's Our Take: Lilly’s, Novo Nordisk’s share prices roller-coaster following earnings reports
Darwin's Our Take: Botox, Trulicity, Xolair among drugs selected for next round of Medicare price negotiations
Subscribe to Our Take
Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.
